Literature DB >> 33306076

pH-Sensitive nanogels for drug delivery in cancer therapy.

Zhen Li1, Jun Huang2, Jun Wu1.   

Abstract

As a commonly used treatment method for cancer, chemotherapy is greatly limited by the side effects of chemotherapy drugs and the multiple drug resistance that develops. Nanogels are considered ideal drug carriers due to their high stability, high water content and excellent drug loading capacities. To achieve more precise and intelligent drug delivery in tumor tissues, various environmentally responsive nanogels have been widely developed. Compared to normal tissue, tumor tissue exhibits a lower pH value. Therefore, the pH gradients between the tumor microenvironment and the normal physiological environment can be used to design pH-sensitive nanogels to regulate the delivery and release of antitumor drugs. This article mainly introduces the application of pH-sensitive nanogels in cancer treatment, hoping to provide a reference for the development of cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33306076     DOI: 10.1039/d0bm01729a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  10 in total

1.  Cisplatin and oleanolic acid Co-loaded pH-sensitive CaCO3 nanoparticles for synergistic chemotherapy.

Authors:  Muhammad Waseem Khan; Chenming Zou; Said Hassan; Fakhar Ud Din; Mahaman Yacoubou Abdoul Razak; Asif Nawaz; Abdul Wahab; Sudhair Abbas Bangash
Journal:  RSC Adv       Date:  2022-05-16       Impact factor: 4.036

Review 2.  Syntheses of Polypeptides and Their Biomedical Application for Anti-Tumor Drug Delivery.

Authors:  Huayang Feng; Jonas Fabrizi; Jingguo Li; Christian Mayer
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

3.  Synthesis and Design of Purpurin-18-Loaded Solid Lipid Nanoparticles for Improved Anticancer Efficiency of Photodynamic Therapy.

Authors:  Sooho Yeo; Hyeon Ho Song; Min Je Kim; Seokhyeon Hong; Il Yoon; Woo Kyoung Lee
Journal:  Pharmaceutics       Date:  2022-05-15       Impact factor: 6.525

4.  Unravelling the Supramolecular Driving Forces in the Formation of CO2-Responsive Pseudopeptidic Low-Molecular-Weight Hydrogelators.

Authors:  Ferran Esteve; Alexis Villanueva-Antolí; Belén Altava; Eduardo García-Verdugo; Santiago V Luis
Journal:  Gels       Date:  2022-06-20

5.  A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy.

Authors:  Yun-Chang Zhang; Pei-Yu Zeng; Zhi-Qiang Ma; Zi-Yue Xu; Ze-Kun Wang; Beibei Guo; Feng Yang; Zhan-Ting Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 6.  Tumor acidity: From hallmark of cancer to target of treatment.

Authors:  Alexey Bogdanov; Andrey Bogdanov; Viacheslav Chubenko; Nikita Volkov; Fedor Moiseenko; Vladimir Moiseyenko
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

7.  Phenylboronic acid conjugated multifunctional nanogels with 131I-labeling for targeted SPECT imaging and radiotherapy of breast adenocarcinoma.

Authors:  Lingdan Kong; Jingyi Zhu; Hongxing Su; Lingzhou Zhao; Yi Lu; Meilin Zhu; Wenjie Sun
Journal:  Front Bioeng Biotechnol       Date:  2022-07-22

8.  Synthesis and Characterization of a Novel Dual-Responsive Nanogel for Anticancer Drug Delivery.

Authors:  Darya Aminoleslami; Sahar Porrang; Parviz Vahedi; Soodabeh Davaran
Journal:  Oxid Med Cell Longev       Date:  2022-09-19       Impact factor: 7.310

9.  Design and Characterisation of pH-Responsive Photosensitiser-Loaded Nano-Transfersomes for Enhanced Photodynamic Therapy.

Authors:  Sooho Yeo; Il Yoon; Woo Kyoung Lee
Journal:  Pharmaceutics       Date:  2022-01-16       Impact factor: 6.321

10.  A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy.

Authors:  Yun-Chang Zhang; Pei-Yu Zeng; Zhi-Qiang Ma; Zi-Yue Xu; Ze-Kun Wang; Beibei Guo; Feng Yang; Zhan-Ting Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.